Cargando…

The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

BACKGROUND: Great success has been made in the targeting therapy of advanced non-small cell lung cancer (NSCLC). Nowadays, next generation sequencing (NGS) is acquirable and affordable in developed area of China. Using this feasible and accurate method of detecting therapeutic genes would help to se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Shen, Wen-Xiang, Zhou, Li-Na, Tang, Min, Tan, Yue, Feng, Chun-Xia, Li, Ping, Wang, Li-Qiang, Chen, Min-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003276/ https://www.ncbi.nlm.nih.gov/pubmed/32047821 http://dx.doi.org/10.1155/2020/9387167

Ejemplares similares

Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients
por: Li, Jun, et al.
Publicado: (2022)

Real-world evidence for option value in metastatic melanoma
por: Wong, William B, et al.
Publicado: (2021)

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing
por: Ahn, Beung-Chul, et al.
Publicado: (2023)

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Alectinib versus crizotinib in ALK‐positive advanced non‐small cell lung cancer and comparison of next‐generation TKIs after crizotinib failure: Real‐world evidence
por: Wang, Yurong, et al.
Publicado: (2022)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Beads and Beyond: An Observational Study to Generate Real World Evidence on Various Brands of Itraconazole
por: Kar, Debjit, et al.
Publicado: (2022)

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
por: Suh, Koung Jin, et al.
Publicado: (2022)

Observational designs for real-world evidence studies
por: Taur, Santosh Ramesh
Publicado: (2022)

A case of disseminated Legionnaires’ disease: The value of metagenome next-generation sequencing in the diagnosis of Legionnaires
por: Li, Shan, et al.
Publicado: (2022)

Diagnostic value of metagenomics next-generation sequencing technology in disseminated strongyloidiasis
por: Song, Peng, et al.
Publicado: (2022)

The value of real world evidence: The case of medical cannabis
por: Schlag, Anne Katrin, et al.
Publicado: (2022)

Herpes simplex virus associated sepsis in an immunocompetent adult: the value of next-generation sequencing
por: Li, Shan, et al.
Publicado: (2020)

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience
por: Kim, Yoo-Na, et al.
Publicado: (2023)

Real world evidence: experience and lessons from China
por: Sun, Xin, et al.
Publicado: (2018)

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
por: Colomer, Ramon, et al.
Publicado: (2023)

Real-world Evidence of the Herb-drug Interactions
por: Pan, Hsueh-Yi, et al.
Publicado: (2022)

Case Report: Diagnostic Value of Metagenomics Next Generation Sequencing in Intracranial Infection Caused by Mucor
por: Liu, YuChen, et al.
Publicado: (2021)

The diagnostic value of metagenomic next⁃generation sequencing in infectious diseases
por: Duan, Hongxia, et al.
Publicado: (2021)

Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases
por: Su, Rui, et al.
Publicado: (2022)

The diagnostic value of next-generation sequencing technology in sepsis
por: Cao, Xiao-guang, et al.
Publicado: (2022)

Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
por: Dai, Wei Fang, et al.
Publicado: (2022)

Strategies to Address Current Challenges in Real-World Evidence Generation in Japan
por: Laurent, Thomas, et al.
Publicado: (2023)

A causal roadmap for generating high-quality real-world evidence
por: Dang, Lauren E., et al.
Publicado: (2023)

Risk factor analysis of device-related infections: value of re-sampling method on the real-world imbalanced dataset
por: Feng, Xiang-Fei, et al.
Publicado: (2019)

Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients
por: Hempel, Dirk, et al.
Publicado: (2020)

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
por: Takahashi, Toshiaki, et al.
Publicado: (2023)

Clinical outcomes of KRAS-mutant non-small cell lung cancer under untargeted therapeutic regimes in the real world: a retrospective observational study
por: Wang, Ming-Ming, et al.
Publicado: (2023)

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation?
por: Khosla, Sajan, et al.
Publicado: (2018)

Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
por: Arlett, Peter, et al.
Publicado: (2021)

To Repair the World: Paul Farmer Speaks to the Next Generation
por: Schmidt, Barbara
Publicado: (2013)

Automating Access to Real-World Evidence
por: Gauthier, Marie-Pier, et al.
Publicado: (2022)

Generating real-world evidence compatible with evidence from randomized controlled trials: a novel observational study design applicable to surgical transfusion research
por: Yu, Xiaochu, et al.
Publicado: (2022)

Increasing trust in real-world evidence through evaluation of observational data quality
por: Blacketer, Clair, et al.
Publicado: (2021)

Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer
por: Remon, Jordi, et al.
Publicado: (2019)

MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting
por: Schubart, Christoph, et al.
Publicado: (2021)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
por: Song, Peng, et al.
Publicado: (2020)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ln31t4thlci31ecpro610tvgn9